ProQR Therapeutics NV (PRQR) Transcripts

ProQR Therapeutics Virtual Investor Event Transcript
Apr 08, 2026
ProQR Therapeutics NV R&D Day Transcript
Mar 29, 2023
ProQR Therapeutics NV Lilly Partnership Expansion and Axiomer Overview Transcript
Dec 22, 2022
ProQR Therapeutics NV Management Call Transcript
Aug 11, 2022
ProQR Therapeutics NV Additional Sepofarsen Analyses and Company Strategy Update Call Transcript
Apr 13, 2022
ProQR Therapeutics NV Top-Line Results Phase 2/3 Illuminate Trial - Corporate Call Transcript
Feb 11, 2022
ProQR Therapeutics NV Analyst Event Transcript
Nov 18, 2021
ProQR Therapeutics NV at Chardan Genetic Medicines Conference (Virtual) Transcript
Oct 05, 2021
ProQR Therapeutics NV at Citi BioPharma Conference (Virtual) Transcript
Sep 09, 2021
ProQR Therapeutics NV Axiomer RNA Call Transcript
Sep 09, 2021
ProQR Therapeutics NV Review of Phase 1/2 Stellar Data in Usher/nsRP Hosted By Cantor Fitzgerald Transcript
Mar 25, 2021
ProQR Therapeutics NV to Discuss the Results of Phase 1/2 Stellar trial of QR-421a in Adults with Usher Syndrome and nSRP Transcript
Mar 24, 2021
ProQR Therapeutics NV at H C Wainwright Global Life Sciences Conference (Virtual) Transcript
Mar 09, 2021
ProQR Therapeutics NV Expert Perspectives Call Transcript
Feb 22, 2021
Apellis Pharmaceuticals Inc, Aerie Pharmaceuticals, Aldeyra Therapeutics, and ProQR Therapeutic at Citi BioPharma Conference (Virtual) - Panel Transcript
Sep 10, 2020
ProQR Therapeutics NV Expert Perspectives Series -- LCA10 and Sepofarsen - Call Transcript
Jul 20, 2020
ProQR Therapeutics NV Expert Perspectives Series -- Usher Syndrome and Retinitis Pigmentosa - Call Transcript
Jun 22, 2020

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.